Filing Details
- Accession Number:
- 0001104659-23-079686
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-10 16:42:44
- Reporting Period:
- 2023-07-06
- Accepted Time:
- 2023-07-10 16:42:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1640266 | Voyager Therapeutics Inc. | VYGR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1944011 | Alfred Todd Carter | C/O Voyager Therapeutics, Inc. 64 Sidney Street Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-07-06 | 5,500 | $10.80 | 59,860 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported sale of 5,500 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.